These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17011048)

  • 1. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.
    Kumar M; Putzki N; Limmroth V; Remus R; Lindemann M; Knop D; Mueller N; Hardt C; Kreuzfelder E; Grosse-Wilde H
    J Neuroimmunol; 2006 Nov; 180(1-2):178-84. PubMed ID: 17011048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
    Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
    J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses.
    Venken K; Thewissen M; Hellings N; Somers V; Hensen K; Rummens JL; Stinissen P
    J Immunol Methods; 2007 Apr; 322(1-2):1-11. PubMed ID: 17368474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis.
    Lewkowicz N; Lewkowicz P; Dzitko K; Kur B; Tarkowski M; Kurnatowska A; Tchórzewski H
    J Oral Pathol Med; 2008 Sep; 37(8):454-61. PubMed ID: 18318707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study.
    Putzki N; Kumar M; Kreuzfelder E; Grosse-Wilde H; Diener HC; Limmroth V
    Eur Neurol; 2009; 61(1):27-32. PubMed ID: 18948697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients.
    Feger U; Luther C; Poeschel S; Melms A; Tolosa E; Wiendl H
    Clin Exp Immunol; 2007 Mar; 147(3):412-8. PubMed ID: 17302889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma.
    Lee JH; Yu HH; Wang LC; Yang YH; Lin YT; Chiang BL
    Clin Exp Immunol; 2007 Apr; 148(1):53-63. PubMed ID: 17349011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment.
    Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Assunta B; Plantone D; Cammarota G; Tonali PA; Batocchi AP
    Hum Immunol; 2009 Jun; 70(6):430-5. PubMed ID: 19364517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatigue is not associated with impaired function of regulatory T cells in untreated patients with multiple sclerosis.
    Yaldizli O; Kumar M; Vago S; Kreuzfelder E; Limmroth V; Putzki N
    Eur Neurol; 2009; 62(6):321-6. PubMed ID: 19752558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
    Li L; Lao SH; Wu CY
    Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
    Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE
    Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.
    Saresella M; Marventano I; Longhi R; Lissoni F; Trabattoni D; Mendozzi L; Caputo D; Clerici M
    FASEB J; 2008 Oct; 22(10):3500-8. PubMed ID: 18587005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.